News RSS Bioethics News.

11/10/2016

U.S. watchdog told Medicare, Medicaid that EpiPen was misclassified in 2009: senator

External Link - Source: Reuters

The internal watchdog at the U.S. Department of Health and Human Services warned the office tasked with administering federal health insurance programs that Mylan NV’s EpiPen was improperly classified as a generic drug in 2009, Senator Charles Grassley said on Tuesday.